Embryonal Rhabdomyosarcoma

Observed

→ investigated in trials for

Dactinomycinother

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall_molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall_molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall_molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall_molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall_molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinorelbinesmall_molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cixutumumabmonoclonal_antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dinutuximab Betamonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganitumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall_molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Embryonal Rhabdomyosarcoma studied in …STUDIED_INderived10 of 17show all (up to 200)
→ studied in	NCT02567435Phase 3 · active not recruiting Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)	—	—	Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05304585Phase 3 · recruiting Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)	—	—	Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04994132Phase 3 · active not recruiting A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)	—	—	Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03296371active not recruiting Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)	—	—	Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03382158recruiting International PPB/DICER1 Registry · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)	—	—	Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06669013Phase 3 · recruiting Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)	—	—	Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00354835Phase 3 · completed Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)	—	—	Childhood Botryoid-Type Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03041701Phase 1/Phase 2 · terminated Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)	—	—	Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00075582Phase 3 · completed Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma · condition mapped ALIAS · 17 trials mapped (6 active)	—	—	Childhood Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00923351Phase 1/Phase 2 · completed Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma · condition mapped ALIAS · 17 trials mapped (6 active)	—	—	Embryonal Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →

Embryonal Rhabdomyosarcoma studied in …STUDIED_INderived10 of 17show all (up to 200)

→ studied in

NCT02567435Phase 3 · active not recruiting

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)

—

Observed

→ studied in

NCT05304585Phase 3 · recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)

—

Observed

→ studied in

NCT04994132Phase 3 · active not recruiting

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)

—

Observed

→ studied in

NCT03296371active not recruiting

Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)

—

Observed

→ studied in

NCT03382158recruiting

International PPB/DICER1 Registry · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)

—

Observed

→ studied in

NCT06669013Phase 3 · recruiting

Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)

—

Observed

Childhood Botryoid-Type Embryonal Rhabdomyosarcoma

→ studied in

NCT00354835Phase 3 · completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)

—

Observed

→ studied in

NCT03041701Phase 1/Phase 2 · terminated

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (6 active)

—

Observed

Childhood Embryonal Rhabdomyosarcoma

→ studied in

NCT00075582Phase 3 · completed

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma · condition mapped ALIAS · 17 trials mapped (6 active)

—

Observed

→ studied in

NCT00923351Phase 1/Phase 2 · completed

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma · condition mapped ALIAS · 17 trials mapped (6 active)

—

Observed